Monitoring van de stolling bij jonge ECMO patiente
- Conditions
- ECMOCoagulationStollingchildkind
- Registration Number
- NL-OMON20511
- Lead Sponsor
- ErasmusMC Sophia Children's Hospital, Rotterdam
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 160
Inclusion Criteria
Children from 0 to 18 years old treated with ECMO therapy can be included in this study within 48 hours after start of ECMO and after obtained informed consent.
Exclusion Criteria
1. Patients without informed consent
2. Patients after 48 hours of start of ECMO
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Bleeding complications in the first 14 days of ECMO therapy<br /> <br>2.Clotting complications in the first 14 days of ECMO therapy<br>
- Secondary Outcome Measures
Name Time Method